$OXBR

OXBRIDGE RE HOLDINGS Ltd

CIK:0001584831|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue
Assumed premiums	$ 314	$ 2,222	$ 314	$ 2,222
Change in unearned premiums reserve	54	(1,640)	610	(1,046)
Net premiums earned	368	582	924	1,176
SurancePlus management fee income	501	1	501	1
Net investment and other income	71	93	139	173
Realized gain on other investments				35
Unrealized loss on other investments				(20)
Change in fair value of equity securities		(12)		(9)
Total revenue	940	664	1,564	1,356
Expenses
Losses and loss adjustment expenses		2,293		2,293
Policy acquisition costs and underwriting expenses	44	64	105	129
General and administrative expenses	603	1,257	1,126	1,762
Total expenses	647	3,614	1,231	4,184
Income (loss) before income / loss attributable to tokenholders and non-controlling interests	293	(2,950)	333	(2,828)
(Income) loss attributable to tokenholders	(1)	946	(3)	699
Income (loss) before income / loss attributable to non-controlling interests	292	(2,004)	330	(2,129)
(Income) loss attributable to non-controlling interests	(116)	131	(132)	117
Net income (loss) attributable to ordinary shareholders	$ 176	$ (1,873)	$ 198	$ (2,012)
Income (loss) per share attributable to ordinary shareholders
Basic	$ 0.02	$ (0.25)	$ 0.02	$ (0.28)
Diluted	$ 0.02	$ (0.25)	$ 0.02	$ (0.28)
Weighted-average shares outstanding
Basic	8,101,374	7,442,922	7,961,597	7,174,014
Diluted	8,101,374	7,442,922	7,961,597	7,174,014

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net income (loss) attributable to ordinary shareholders	$ 176	$ (1,873)	$ 198	$ (2,012)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Share-based compensation			127	178
Realized gain on other investments				(35)
SurancePlus management fee income	(501)	(1)	(501)	(1)
Depreciation and amortization			2
Change in fair value of other investments				20
Change in fair value of equity securities		12		9
Income (loss) attributable to non-controlling interests	116	(131)	132	(117)
Change in operating assets and liabilities:
Operating right-of-use asset			(70)	52
Operating lease liabilities			70	(52)
Premiums receivable			459	(918)
Deferred policy acquisition costs			67	(115)
Prepayment and other assets			18	(23)
Reserve for loss and loss adjustment expenses				175
Premium payable			31
Unearned premiums reserve			(610)	1,046
Accounts payable and other liabilities			20	(106)
Net cash used in operating activities			(57)	(1,899)
Investing activities
Proceeds from sale of other investments				63
Net cash provided by investing activities				63
Financing activities
Proceeds from issuance (redemption) of Tokenholders			40	(526)
Proceeds from issuance of ordinary shares			342	3,122
Proceeds from issuance of HCI 2026 Series A, B & C Tokens			6,323
Proceeds from HCI Additional Collateral Deposit			6,198
Net cash provided by financing activities			12,903	2,596
Cash and cash equivalents, and restricted cash and cash equivalents:
Net change during the period			12,846	760
Balance at beginning of period			6,976	5,893
Balance at end of period	$ 19,822	$ 6,653	19,822	6,653
Non-cash investing and financing activities
Right-of-use lease asset obtained in exchange for operating lease liabilities			89
Reclassification of contributed non-controlling interest			3	104
Reclassification of other liabilities EpsilonCat Re / DeltaCat Re				$ 1,732

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Assets
Cash and cash equivalents	$ 4,111	$ 268
Premiums receivable	307	766
Deferred policy acquisition costs	35	102
Operating lease right-of-use assets	62	43
Prepayment and other assets	132	150
Property and equipment, net	14	16
Total assets	20,372	8,053
Liabilities:
Reserve for losses and loss adjustment expenses	91	91
Notes payable to noteholders	118	118
Premium payable	31
Unearned premiums reserve	316	926
Losses payable	73	73
Operating lease liabilities	62	43
Accounts payable and other liabilities	329	309
Total liabilities	1,020	1,560
Mezzanine Equity
Total Mezzanine equity	12,578	518
Shareholders’ equity:
Ordinary share capital, (par value $0.001, 500,000,000 shares authorized; 8,101,374 and 7,664,122 shares issued and outstanding)	6	6
Additional paid-in capital	38,516	38,047
Accumulated Deficit	(31,936)	(32,137)
Total Oxbridge shareholders’ equity	6,586	5,916
Non-controlling interests	188	59
Total shareholders’ equity	6,774	5,975
Total liabilities, mezzanine and shareholders’ equity	20,372	8,053
Cat Re Token Program [Member]
Assets
Restricted cash and cash equivalents	3,691	6,708
HCI 2026 Token Program [Member]
Assets
Restricted cash and cash equivalents	12,020
Cat Re / T20 / T42 tokenholders [Member]
Mezzanine Equity
Total Mezzanine equity	558	518
HCI 2026 Series A Tokens [Member]
Mezzanine Equity
Total Mezzanine equity	3,600
HCI 2026 Series B Tokens [Member]
Mezzanine Equity
Total Mezzanine equity	4,900
HCI 2026 Series C Tokens [Member]
Mezzanine Equity
Total Mezzanine equity	$ 3,520